$2.090
+0.051 (+2.45%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Fate Therapeutics Inc (FATE) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting FATE is Buy.
Fate Therapeutics Inc (FATE) 20-Day simple moving average is 2.05, while Fate Therapeutics Inc (FATE) share price is $—, making it Buy.
Fate Therapeutics Inc (FATE) 60-Day simple moving average is 2.31, while Fate Therapeutics Inc (FATE) share price is $—, making it Sell.
Technical Analysis for FATE
AI Technical FATEAs of 2026-11-03, the technical board for Fate Therapeutics Inc (FATE) reads buy: 6 indicators are flashing buy, 3 are indicating sell, and 4 are neutral. Price at $2.09 sits below the 60-day moving averages and above the 5-day, 10-day, 20-day and 200-day.
Momentum readings: RSI stands at 47.118, MACD stands at -0.0528 (Sell), Stochastic %K stands at 61.806, Stochastic %D stands at 64.352 and CCI stands at 21.657.
FATE trades below the 60-day SMA (2.31) and above the 200-day SMA (1.97). Immediate resistance sits at Classic R1 2.22, then R2 2.35. Support sits at Classic S1 1.97, then S2 1.85.
Fate Therapeutics Inc (FATE) Support & Resistance Level
Fate Therapeutics Inc (FATE) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 47.118 |
| STOCHk_14_3_3 | 61.806 |
| STOCHd_14_3_3 | 64.352 |
| CCI_20 | 21.657 |
| AO_5_34 | -0.105 |
| MOM_10 | 0.020 |
| MACD_12_26_9 | -0.053 |
Fate Therapeutics Inc (FATE) Relative Strength Index (RSI_14) is 47.118, creating a Neutral signal.
Fate Therapeutics Inc (FATE) Stochastic %K is 61.806, creating a Neutral signal.
Fate Therapeutics Inc (FATE) Stochastic %D is 64.352, creating a Neutral signal.
Fate Therapeutics Inc (FATE) CCI_20 is 21.657, creating a Neutral signal.
Fate Therapeutics Inc (FATE) Awesome Oscillator (AO) is -0.105, creating a Sell signal.
Fate Therapeutics Inc (FATE) Momentum (MOM) is 0.020, creating a Buy signal.
Fate Therapeutics Inc (FATE) Moving Average Convergence Divergence (MACD) is -0.053, creating a Sell signal.
Fate Therapeutics Inc (FATE) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 2.078 | Buy |
| MA_10 | 2.089 | Buy |
| MA_20 | 2.048 | Buy |
| MA_60 | 2.312 | Sell |
| MA_200 | 1.971 | Buy |
| MA_250 | 1.787 | Buy |
Fate Therapeutics Inc (FATE) 5-Day simple moving average is 2.078, while Fate Therapeutics Inc (FATE) share price is $, making it a Buy.
Fate Therapeutics Inc (FATE) 10-Day simple moving average is 2.089, while Fate Therapeutics Inc (FATE) share price is $, making it a Buy.
Fate Therapeutics Inc (FATE) 20-Day simple moving average is 2.048, while Fate Therapeutics Inc (FATE) share price is $, making it a Buy.
Fate Therapeutics Inc (FATE) 60-Day simple moving average is 2.312, while Fate Therapeutics Inc (FATE) share price is $, making it a Sell.
Fate Therapeutics Inc (FATE) 200-Day simple moving average is 1.971, while Fate Therapeutics Inc (FATE) share price is $, making it a Buy.
Fate Therapeutics Inc (FATE) 250-Day simple moving average is 1.787, while Fate Therapeutics Inc (FATE) share price is $, making it a Buy.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.